Operating Lease, Right-of-Use Asset in USD of scPharmaceuticals Inc. from Q4 2017 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
scPharmaceuticals Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2017 to Q2 2025.
  • scPharmaceuticals Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $1,175,000, a 10% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

scPharmaceuticals Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,175,000 -$134,000 -10% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,236,000 -$119,000 -8.8% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $1,273,000 -$128,000 -9.1% 31 Dec 2024 10-Q 07 Aug 2025 2025 Q2
Q3 2024 $1,330,000 -$205,000 -13% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $1,309,000 +$946,000 +261% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $1,355,000 +$889,000 +191% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $1,401,000 +$835,000 +148% 31 Dec 2023 10-K 19 Mar 2025 2024 FY
Q3 2023 $1,535,000 +$858,000 +127% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $363,000 -$422,000 -54% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $466,000 +$148,000 +47% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $566,000 +$156,000 +38% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $677,000 +$164,000 +32% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $785,000 +$169,000 +27% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $318,000 -$399,000 -56% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $410,000 -$405,000 -50% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $513,000 -$397,000 -44% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $616,000 -$386,000 -39% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $717,000 -$375,000 -34% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $815,000 -$364,000 -31% 31 Dec 2020 10-K 22 Mar 2022 2021 FY
Q3 2020 $910,000 -$354,000 -28% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $1,002,000 -$345,000 -26% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $1,092,000 -$335,000 -23% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $1,179,000 -$327,000 -22% 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q3 2019 $1,264,000 -$318,000 -20% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $1,347,000 -$282,000 -17% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $1,427,000 -$275,000 -16% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $1,506,000 -$267,000 -15% 31 Dec 2018 10-K 24 Mar 2020 2019 FY
Q3 2018 $1,582,000 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 $1,629,000 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 $1,702,000 31 Mar 2018 10-Q 07 May 2018 2018 Q1
Q4 2017 $1,773,000 31 Dec 2017 10-K 21 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.